Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Therapeutics and Clinical Risk Management|April 12, 2011
Broadening the use of antiretroviral therapy: the case for feline leukemia virusWillie M Greggs, Christine L Clouser, Steven E Patterson, et al.Current Protocols in Nucleic Acid Chemistry|April 23, 2008
Nucleoside-5'-phosphoimidazolides: reagents for facile synthesis of dinucleoside pyrophosphatesLiqiang Chen, Dominik Rejman, Laurent Bonnac, et al.The Journal of General Virology|January 20, 2012
Discovery of drugs that possess activity against feline leukemia virusWillie M Greggs, Christine L Clouser, Steven E Patterson, et al.Toxicology Letters|April 17, 2017
In-vitro mercaptopyruvate sulfurtransferase species comparison in humans and common laboratory animalsBryant M Moeller, Daune L Crankshaw, Jacquie Briggs, et al.The Journal of General Virology|August 9, 2014
Novel inhibitors of human immunodeficiency virus type 2 infectivityLauren B Beach, Jonathan M Rawson, Baek Kim, et al.Bioorganic & Medicinal Chemistry Letters|January 30, 2007
Rational design and synthesis of novel nucleotide anti-Giardia agentsDae-Hwan Suk, Laurent Bonnac, Christine C Dykstra, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2024
Synthesis and evaluation of anti-Giardia activity of oseltamivir analogsHarrison W VanKoten, Breanna C Pence, James R Klinkenberg, et al.Journal of Medicinal Chemistry|November 28, 2007
Novel, orally effective cyanide antidotesHerbert T Nagasawa, David J W Goon, Daune L Crankshaw, et al.Organic Letters|September 23, 2010
Phosphonoxins III: synthesis of α-aminophosphonate analogs of antifungal polyoxins with anti-Giardia activityMichael Staake, Jay Chauhan, Ding Zhou, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2020
Triazoxins: Novel nucleosides with anti-Giardia activityPraveen K Pogula, Atasi De Chatterjee, Miguel Chi, et al.Pageof 6